YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Image source: The Motley Fool. DATE Tuesday, Aug. 18, 2026 at 5 p.m. ET CALL PARTICIPANTS Investor Relations - Trip Taylor Chief Executive Officer - Patrick Mercer Chief Financial Officer - Romeo R. Dizon Full Conference Call Transcript Op…
IRIDEX Corporation Q2 2026 Earnings Call Summary - Moby Strategic Transformation and Operational Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our…
Earnings Call Insights: IRIDEX Corporation (IRIX) Q2 2026 MANAGEMENT VIEW * "If there is one message I want to leave you with today, it is that IRIDEX has reached an important inflection point in its financial profile. We generated positiv…
Shares of IRIDEX Corporation IRIX have gained 3.6% since the company reported earnings for the quarter ended April 4, 2026, outperforming the S&P 500 index’s 0.6% increase over the same period. However, over the past month, the stock has d…
IRIDEX Corporation Q1 2026 Earnings Call Summary - Moby Strategic Performance and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1…
Earnings Call Insights: IRIDEX Corporation (IRIX) Q1 2026 MANAGEMENT VIEW * CEO Patrick Mercer said the company stayed focused on profitability and cash generation, stating, "we remain on track to be cash flow positive in 2026," while noti…
For Immediate Releases Chicago, IL – April 20, 2026 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the fi…
Friday, April 17, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp. (MSFT), AbbVie Inc. (ABBV) and BHP Gr…
Shares of Iridex Corporation IRIX have declined 23.8% since the company reported its earnings for the quarter ended Jan. 3, 2026, underperforming the S&P 500 index’s 3.9% decline over the same period. Over the past month, the stock has fal…
IRIDEX Corporation Q4 2025 Earnings Call Summary - Moby Strategic Transformation and Operational Drivers Achieved positive adjusted EBITDA for the first time in recent history by growing revenue 8% while slashing operating expenses by 22%…
Image source: The Motley Fool. DATE Thursday, March 26, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Patrick Mercer Chief Financial Officer — Romeo Dizon Full Conference Call Transcript Patrick Mercer, IRIDEX Corporation's…
Image source: The Motley Fool. DATE Thursday, March 26, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Patrick MercerChief Financial Officer — Romeo Dizon TAKEAWAYS Full-Year Revenue -- $52.7 million, representing 8% growth;…
NEW YORK, NY / ACCESS Newswire / December 9, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day Year-End Virtual Investor Conference taking place Wednesday…
MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma…
MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma…
MOUNTAIN VIEW, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glau…
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied…
* Ophthalmic medical technology company, Iridex (NASDAQ:IRIX [https://seekingalpha.com/symbol/IRIX]) on Tuesday said that it has received formal notice from Nasdaq confirming it has regained compliance with continued listing standards. * T…
MOUNTAIN VIEW, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of gla…
This article summarizes the most significant insider buys and sells reported for US stocks on Tuesday, August 19, 2025. Top Insider Buys: Atara Biotherapeutics, Inc. (NASDAQ:ATRA) saw Director James Huang purchase 55,000 shares of common s…
Director William M. Moore of Iridex Corp (NASDAQ:IRIX), a micro-cap medical technology company valued at $19.63 million, recently purchased 12,024 shares of common stock. The shares were bought at a weighted average price of $1.1834, for a…
Iridex Corp (NASDAQ:IRIX) Chief Financial Officer Romeo R. Dizon acquired shares of common stock in two transactions on August 18, 2025, showing insider confidence despite the stock’s 31% decline year-to-date. According to InvestingPro ana…
Romeo R. Dizon, Chief Financial Officer of Iridex Corp (NASDAQ:IRIX), recently purchased shares of the company’s common stock. According to a Form 4 filing with the Securities and Exchange Commission, Dizon acquired a total of 1,500 shares…
Key Points Total GAAP revenue for Q2 2025 grew 7.0% year over year to $13.6 million. GAAP gross margin narrowed to 34.5% in Q2 2025, driven by higher manufacturing costs and changes in product and geographic mix. Operating expenses fell 28…
Earnings Call Insights: IRIDEX Corporation (IRIX) Q2 2025 MANAGEMENT VIEW * CEO Patrick Mercer highlighted that IRIDEX achieved year-over-year revenue growth, operating expense reductions, and positive adjusted EBITDA for the third consecu…
IRIDEX Corporation (IRIX) reported its second-quarter earnings for 2025, showcasing a better-than-expected performance with an EPS of -$0.06, surpassing the forecasted -$0.09. The company also exceeded revenue expectations, reporting $13.6…
MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glau…
WALTHAM, Mass. - Surgical robotics company Vicarious Surgical Inc. (NYSE:RBOT), currently valued at $1.59 billion and showing strong momentum with a 27.61% gain last week, announced Monday the election of Fuad Ahmad and Joseph Doherty to i…
William M. Moore, a director at Iridex Corp (NASDAQ:IRIX), has recently acquired 20,000 shares of the company’s common stock, according to a filing with the Securities and Exchange Commission. The medical technology company, currently valu…
IRIDEX Corporation (NASDAQ:IRIX), a provider of innovative ophthalmic laser-based medical products currently trading at $0.94 per share, announced the results of its 2025 Annual Meeting of Stockholders held on June 11, 2025. According to I…
In recent transactions, William M. Moore, a director at Iridex Corp (NASDAQ:IRIX), purchased a total of 30,000 shares of common stock over two days. The insider buying comes as the stock trades near $0.96, having declined over 45% in the p…
MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glau…
MOUNTAIN VIEW, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of gla…
MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of gla…
MOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal d…
MOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal d…